The global human microbiome market is anticipated to show at a CAGR 23.52% over the forecast period. The Human Microbiome is referred as the aggregate of all microbiome which reside within or on human tissues and biofluids along with the corresponding anatomical sites in which they reside such as mammary glands, skin, uterus, seminal fluid, lung, saliva, and gastrointestinal tract.
The increase in incidence of lifestyle diseases and the rise in focus on human micribiome therapies is expected to boost the global human microbiome market growth over the forecast period. Further, the rise in technological advancements in meta-genomics and next-generation sequencing will positively influence the global human microbioime market. Also the rise in aging population will drive the market growth. In addition to that, the rise in partnership, collaboration, and mergers and acquisition activities by key operating players will propel the global human microbiome market growth over the forecast period.
Lack of qualified personnel and detailed research is the major restraint which is expected to hinder the global human microbiome market. Also, stringent government regulations will limit the global human microbiome market growth during this forecast timeline.
The Global Human Microbiome Market is segmented into Product such as Prebiotic, Probiotic, Food, Medical Food, and Drug. Further market is segmented into application (Therapeutic), Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological), and Research Technology (Proteomics, and Metabolomics)
Also, Global Human Microbiome Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in the global human microbiome market report including Enterome, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Synthetic Biologics, Inc, DuPont, BiomX Ltd, MaaT Pharma, and Eligo Bioscience.
By Application Therapeutic Disease Infectious Metabolic/Endocrine Cancer Blood Neurological Research Technology Proteomics Metabolomics
By Region North America Latin America Europe Asia Pacific Middle East & Africa
Key Questions Addressed by the Report What are the Key Opportunities in Global Human Microbiome Market? What will be the growth rate from 2019 to 2030? Which segment/region will have highest growth? What are the factors that will impact/drive the Market? What is the competitive Landscape in the Industry? What is the role of key players in the value chain? What are the strategies adopted by key players?
Global Human Microbiome Market TOC
1 Introduction 1.1 Objective of the Study 1.2 Market definition 1.3 Market Scope
2 Research Methodology
2.1 Data Mining 2.2 Validation 2.3 Primary Interviews 2.4 List of Data Sources
3 Executive Summary 4 Global Human Microbiome Market Outlook 4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis
5 Global Human Microbiome Market, By Product 5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Human Microbiome Market Share Analysis, By Product
5.3 Global Human Microbiome Market Size and Forecast, By Product 5.3.1 Prebiotic
5.3.2 Probiotic
5.3.3 Food
5.3.4 Medical Food
5.3.5 Drug
6 Global Human Microbiome Market, By Application 6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Human Microbiome Market Share Analysis, By Application
6.3 Global Human Microbiome Market Size and Forecast, By Application 6.3.1 Therapeutic 6.3.3.1.1 Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, Neurological)
6.3.3.1.2 Research Technology (Proteomics, Metabolomics)
7Global Human Microbiome Market, By Region 7.1 Global Human Microbiome Market Share Analysis, By Region
7.2 Global Human Microbiome Market Share Analysis, By Region
7.3 Global Human Microbiome Market Size and Forecast, By Region
8North America Human Microbiome Market Analysis and Forecast (2020 – 2030) 8.1 Introduction
8.2 North America Human Microbiome Market Share Analysis, By Product
8.3 North America Human Microbiome Market Size and Forecast, By Application
8.4 North America Human Microbiome Market Size and Forecast, By Country
8.4.1 U.S 8.4.2 Canada 8.4.3 Mexico
9Europe Human Microbiome Market Analysis and Forecast (2020 – 2030) 9.1 Introduction
9.2 Europe Human Microbiome Market Share Analysis, By Product
9.3 Europe Human Microbiome Market Size and Forecast, By Application
9.4 Europe Human Microbiome Market Size and Forecast, By Country
9.4.1 Germany 9.4.2 France 9.4.3 UK
9.4.4. Rest of Europe
10Asia Pacific Human Microbiome Market Analysis and Forecast (2020 – 2030) 10.1 Introduction
10.2 Asia Pacific Human Microbiome Market Share Analysis, By Product
10.3 Asia Pacific Human Microbiome Market Size and Forecast, By Application
10.4 Asia Pacific Human Microbiome Market Size and Forecast, By Country
10.4.1 China 10.4.2 Japan 10.4.3 India
10.4.4. Rest of Asia Pacific
11Latin America Human Microbiome Market Analysis and Forecast (2020 – 2030) 11.1 Introduction
11.2 Latin America Human Microbiome Market Share Analysis, By Product
11.3 Latin America Human Microbiome Market Size and Forecast, By Application
11.4 Latin America Human Microbiome Market Size and Forecast, By Country
12Middle East Human Microbiome Market Analysis and Forecast (2020 – 2030) 12.1 Introduction
12.2 Middle East Human Microbiome Market Share Analysis, By Product
12.3 Middle East Human Microbiome Market Size and Forecast, By Application
12.4 Middle East Human Microbiome Market Size and Forecast, By Country
13Competitive Analysis 13.1 Competition Dashboard 13.2 Market share Analysis of Top Vendors 13.3 Key Development Strategies
14Company Profiles
14.1 Enterome
14.1.1 Overview 14.1.2 Offerings 14.1.3 Key Financials 14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Rebiotix Inc.
14.2.1 Overview 14.2.2 Offerings 14.2.3 Key Financials 14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Yakult Honsha Co., Ltd.
14.3.1 Overview 14.3.2 Offerings 14.3.3 Key Financials 14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Osel Inc.
14.4.1 Overview 14.4.2 Offerings 14.4.3 Key Financials 14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Vedanta Biosciences, Inc.
14.5.1 Overview 14.5.2 Offerings 14.5.3 Key Financials 14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6Synthetic Biologics, Inc.
14.6.1 Overview 14.6.2 Offerings 14.6.3 Key Financials 14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 DuPont
14.7.1 Overview 14.7.2 Offerings 14.7.3 Key Financials 14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 BiomX Ltd
14.8.1 Overview 14.8.2 Offerings 14.8.3 Key Financials 14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 MaaT Pharma
14.9.1 Overview 14.9.2 Offerings 14.9.3 Key Financials 14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 Eligo Bioscience
14.10.1 Overview 14.10.2 Offerings 14.10.3 Key Financials 14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies
